deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BIONOMICS LIMITED (ASX.BNO)

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
Former (or subsequent) names

 

Shareholder links
Our website ranking of BNO: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare Adelaide
Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail

Company details
ISIN: AU000000BNO5
Address: 200 GREENHILL ROAD EASTWOOD, SA 5063
Tel:  +61 8 8354 7400 Fax: 08 8354 6199

Date first listed: 21/12/1999
Company Secretary: Suzanne Irwin

Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Biotechnology company creating differentiated, small-molecule drugs for cancer and disorders of the central nervous system

Company lodges a form with ASIC being a notification of the issue of shares.

05/02/2024

Company reports the following corporate highlights: In support of the Company's transformation into a commercial-stage company, expanded the U.S.-based team with new highly experienced management appointments, positioning it to become a leading company in neuropsychiatry. Voluntarily delisted from the Australian Stock Exchange in August 2023 and is currently solely listed on the NASDAQ Global Market. Further reduced cash burn through efficient capital allocation. Maintained its current institutional investors' support while adding new institutional investors to its register. Sustained strong analyst coverage that highlights the Company's potential future value. The Company has no outstanding debt, convertible securities, or warrants. Continued strengthening BNC210 intellectual property portfolio in the U.S. and abroad.

22/01/2024

delisted at entity's request under Listing Rule 17.11

28/08/2023

we understand the company delisted because of low trading volumes on ASX, costs of the listing, leverage gained from the US institutional base, location of directors and management and the geographic location of the largest shareholders - Nasdaq is now its sole listing

28/08/2023

The securities of Bionomics Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of BNO, to facilitate its removal from the official list of ASX Limited.

25/08/2023

shares reinstated to quotation

08/09/2009

shares suspended from quotation following an announcement of an acquisition

07/09/2009

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    20/12/2021Alan Fisher100,000$0.120$12,000
    14/09/2016Peter Turner100,000$0.289$28,944
    01/09/2016Deborah RathjenOn market100,000$0.247$24,735
    12/08/2016David Ian WilsonOn market200,000$0.284$56,720
    11/12/2015Deborah RathjenOn market105,500$0.390$41,178

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    Alan FisherNon Exec Chairman31/08/2016
    Tim CunninghamCFO01/07/2023
    Errol De SouzaNon Exec Director28/02/2008
    Jane RyanNon Exec Director01/10/2020
    David Ian WilsonNon Exec Director16/06/2016
    Miles DaviesNon Exec Director01/07/2021
    Aaron WeaverNon Exec Director06/07/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)
    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Mitchell KayeNon Exec Director23/11/201831/12/2021
    Srinivas RaoNon Exec Director01/10/202001/07/2021
    Peter TurnerNon Exec Director16/06/201620/11/2020
    Stephen BirrellExecutive, CFO24/05/201731/05/2019
    Deborah RathjenCEO18/05/200031/01/2019
    Steven LydeamoreCFO01/08/201723/11/2018
    Melanie YoungCFO13/05/201124/05/2017
    Trevor TappendenNon Exec Director18/09/200608/11/2016
    Graeme KaufmanChairman18/09/201231/08/2016
    Alan DuntonNon Exec Director29/09/201504/07/2016
    Jonathan LimNon Exec Director14/09/201218/11/2015
    Chris FullertonChairman23/12/200831/12/2012
    Peter JonsonNon Exec Chairman18/10/200404/11/2009
    George JessupNon Exec Director01/07/200501/04/2008
    Peter MaddernNon Exec Director04/10/199630/06/2006
    Christopher HenneyNon Exec Director28/02/199830/06/2006
    George MorstynNon Exec Director08/08/200116/06/2006
    Fraser AinsworthChairman01/02/199901/11/2004
    Warren KinstonNon Exec Director08/11/2001

    Date of first appointment, title may have changed.